ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Genentech buys NASH biotech Jecure
pharmaphorum
November 30, 2018Roche’s Genentech unit has bought California biotech Jecure Therapeutics, which is researching drugs that could be used in inflammatory diseases including the fatty liver disease NASH. -
Roche's Genentech to acquire inflammatory drug discovery firm Jecure
pharmafile
November 30, 2018Roche’s subsidiary Genentech has finalised a definitive agreement to acquire Jecure, a US-based biotech which focuses on the discovery of drugs to treat serious inflammatory conditions, in a bid to square up to rivals in the treatment of fatty liver disea
Pharma Sources Insight January 2025
